×
About 312 results

ALLMedicine™ Mycobacterial Infections Center

Research & Reviews  15 results

Atypical mycobacterial infections - management - when to treat.
https://doi.org/10.1097/MCP.0000000000000764
Current Opinion in Pulmonary Medicine; Gill LI, Dominic C et. al.

Feb 9th, 2021 - Infections caused by nontuberculous mycobacteria (NTM) are increasing for several reasons, including diagnostic advances, increased awareness and a larger at-risk population. NTM pulmonary disease is surpassing tuberculosis (TB) in some low incide...

Coexistence of mycobacterial infections - Mycobacterium tuberculosis and Mycobacterium ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364491
Journal of Medical Case Reports; Keragala BSDP, Herath HMMTB et. al.

Jul 16th, 2020 - Leprosy is one of the oldest mycobacterial infections and tuberculosis is the most common mycobacterial infection with a higher degree of infectivity than leprosy. Although both diseases are prevalent in clusters in developing countries, simultane...

Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527651
The European Respiratory Journal; Ong CWM, Migliori GB et. al.

Jun 26th, 2020 - Major epidemics, including some that qualify as pandemics, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A (H1N1)pdm/09 and most recently COVID-19, affect the lung. Tuberculosis (TB) rema...

Study of Mycobacterial Infections
https://clinicaltrials.gov/ct2/show/NCT00018044

Apr 19th, 2020 - The nontuberculous mycobacteria (NTM) are ubiquitous environmental organisms foundin soil and water that rarely cause disease in humans. Since exposure to these organisms is universal and disease is rare, it can be concluded that normal host defen...

Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review.
https://doi.org/10.1016/j.clml.2019.08.008
Clinical Lymphoma, Myeloma & Leukemia; Anand K, Burns EA et. al.

Nov 8th, 2019 - Ruxolitinib is a selective Janus kinase inhibitor (JAKI) 1/2 approved for the treatment of myelofibrosis (MF) and polycythemia vera (PV). These patients may be at risk for developing opportunistic infections. We assessed the number of patients tha...

see more →

Drugs  137 results see all →

Clinicaltrials.gov  159 results

Clarithromycin - clarithromycin for suspension-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fad1e5a3-59f9-4868-9937-d3b061ab8f00

Feb 21st, 2021 - Clarithromycin is a macrolide antimicrobial indicated for mild to moderate infections caused by designated, susceptible bacteria in the following: •Acute Bacterial Exacerbation of Chronic Bronchitis in Adults (1.1) •Acute Maxillary Sinusitis (1.2)...

Clarithromycin - clarithromycin tablet, film coated-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9143b79c-4c79-43ac-e053-2995a90ad708

Feb 18th, 2021 - Clarithromycin tablets are a macrolide antimicrobial indicated for mild to moderate infections caused by designated, susceptible bacteria in the following: Acute Bacterial Exacerbation of Chronic Bronchitis in Adults ( 1.1) Acute Maxillary Sinusit...

Atypical mycobacterial infections - management - when to treat.
https://doi.org/10.1097/MCP.0000000000000764
Current Opinion in Pulmonary Medicine; Gill LI, Dominic C et. al.

Feb 9th, 2021 - Infections caused by nontuberculous mycobacteria (NTM) are increasing for several reasons, including diagnostic advances, increased awareness and a larger at-risk population. NTM pulmonary disease is surpassing tuberculosis (TB) in some low incide...

Clarithromycin - clarithromycin tablet, film coated-Chartwell RX, LLC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=99d2fd6b-39ca-42f9-ad06-30e7fbc22c47

Feb 8th, 2021 - Clarithromycin tablets are a macrolide antimicrobial indicated for mild to moderate infections caused by designated, susceptible bacteria in the following: • Acute Bacterial Exacerbation of Chronic Bronchitis in Adults (1.1) •       Acute Maxillar...

Clarithromycin - clarithromycin tablet, film coated-Denton Pharma, Inc. DBA Northwind Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ba0d460e-fc4a-58fd-e053-2a95a90a4595

Jan 28th, 2021 - Clarithromycin is a macrolide antimicrobial indicated for mild to moderate infections caused by designated, susceptible bacteria in the following: Acute Bacterial Exacerbation of Chronic Bronchitis in Adults (1.1) Acute Maxillary Sinusitis (1.2) C...

see more →

News  1 results

Managing the Adverse Events Caused by Anti-TNF Therapy in Inflammatory Bowel Disease
https://www.medscape.com/viewarticle/909753_3

Conclusion The use of biologics is now a standard therapy for IBD used either as monotherapy or in combination with immunomodulators. A review of safety data of currently used biologics show cumulative evidence for anti-TNF as they have been used ...

see more →